Key Takeaways
- U.S. equities opened mixed in thin August trading, with market sentiment influenced by a fixed bid and anticipation of a Trump-Putin summit scheduled for later this week.
- South Africa's manufacturing production for June significantly exceeded year-over-year expectations, rising 1.9% against an estimated 0.8%, though month-over-month growth remained flat.
- Deutsche Bank made a notable adjustment to its outlook for Eli Lilly and Company (LLY), cutting its target price to $900 from the previous $1,010.
U.S. markets opened on Monday with a mixed performance, characterized by a fixed bid and relatively thin August trading volumes. Investors are closely monitoring geopolitical developments, particularly the upcoming Trump-Putin summit slated for Friday, which is contributing to the cautious sentiment. The prospect of this high-level meeting has generally bolstered global stocks, with hopes for a potential Ukraine ceasefire influencing market direction.
In economic news, South Africa reported its manufacturing production figures for June, revealing a stronger-than-anticipated year-over-year growth. Manufacturing output (NSA Y/Y) increased by 1.9%, significantly surpassing the estimated 0.8% and marking an improvement from the revised previous figure of 0.7%. However, on a month-over-month seasonally adjusted basis (SA M/M), production remained flat at 0.0%, falling short of the 0.4% estimate and declining from the revised prior month's growth of 2.2%.
Meanwhile, Eli Lilly and Company (LLY) saw a significant revision in its analyst outlook from Deutsche Bank. The financial institution has reduced its target price for the pharmaceutical giant to $900 from its earlier $1,010. This adjustment follows previous instances where Deutsche Bank had maintained a $1,010 target price for Eli Lilly.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.